生命科学资讯

RTW's Yarrow to go public in reverse merger with Vyne Therapeutics

Novo Nordisk hit with FDA warning letter over acquired Catalent factory

Vir licensing deal; Cytokinetics wins China nod; Vistagen's social anxiety fail

DBV jumps on phase III data with peanut allergy patch

RA Capital backs drug for rare kind of chronic pain

Thermo Fisher Scientific Inc. $TMO Stock Holdings Lessened by Union Bancaire Privee UBP SA - MarketBeat

AI biotech preview of 2026: Clinic takes center stage

Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery

Post-Hoc Live: Endpoints winners and losers list for 2025

Q1 EPS Forecast for Agilent Technologies Reduced by Analyst - MarketBeat

Alltrna advances tRNA-based strategy for stop codon diseases

Chinese University of Hong Kong describes new SRPK1 inhibitors

New RAC1 inhibitors disclosed in Kong’s Pharmaceutical patent

Osaka University and Tokyo University of Science discover new BBB permeability regulators

Mirador Capital Partners LP Buys 2,253 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Sicart Associates LLC Has $7.89 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat

Oak Thistle LLC Boosts Stake in Waters Corporation $WAT - MarketBeat

Addition emerges with $100M to make gene therapies for chronic and rare diseases

3 key takeaways from the FDA’s new animal testing guidance

How the FDA could soon upend vaccine trials